Trial of Novel Anti-leukemia Agents in Flu/Mel RIC Transplant for Myeloid Malignancies

NCT07044544 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Myeloid Malignancy
Hematologic Malignancy
Acute Myeloid Leukemia
Myelodysplastic Syndromes

Interventions

DRUG: G-CSF
DRUG: Decitabine
DRUG: Venetoclax

Sponsor

University of Alabama at Birmingham